These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 37714432)
1. Multiplexed experimental strategies for fragment library screening against challenging drug targets using SPR biosensors. FitzGerald EA; Vagrys D; Opassi G; Klein HF; Hamilton DJ; Talibov VO; Abramsson M; Moberg A; Lindgren MT; Holmgren C; Davis B; O'Brien P; Wijtmans M; Hubbard RE; de Esch IJP; Danielson UH SLAS Discov; 2024 Jan; 29(1):40-51. PubMed ID: 37714432 [TBL] [Abstract][Full Text] [Related]
2. SPR-based fragment screening: advantages and applications. Neumann T; Junker HD; Schmidt K; Sekul R Curr Top Med Chem; 2007; 7(16):1630-42. PubMed ID: 17979772 [TBL] [Abstract][Full Text] [Related]
3. Establishing Trypanosoma cruzi farnesyl pyrophosphate synthase as a viable target for biosensor driven fragment-based lead discovery. Opassi G; Nordström H; Lundin A; Napolitano V; Magari F; Dzus T; Klebe G; Danielson UH Protein Sci; 2020 Apr; 29(4):991-1003. PubMed ID: 31994261 [TBL] [Abstract][Full Text] [Related]
4. Experimental validation of a fragment library for lead discovery using SPR biosensor technology. Elinder M; Geitmann M; Gossas T; Källblad P; Winquist J; Nordström H; Hämäläinen M; Danielson UH J Biomol Screen; 2011 Jan; 16(1):15-25. PubMed ID: 21149860 [TBL] [Abstract][Full Text] [Related]
5. From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance. Giannetti AM Methods Enzymol; 2011; 493():169-218. PubMed ID: 21371592 [TBL] [Abstract][Full Text] [Related]
6. Fragment library screening and lead characterization using SPR biosensors. Danielson UH Curr Top Med Chem; 2009; 9(18):1725-35. PubMed ID: 19929838 [TBL] [Abstract][Full Text] [Related]
7. Biosensor-based small molecule fragment screening with biolayer interferometry. Wartchow CA; Podlaski F; Li S; Rowan K; Zhang X; Mark D; Huang KS J Comput Aided Mol Des; 2011 Jul; 25(7):669-76. PubMed ID: 21660516 [TBL] [Abstract][Full Text] [Related]
8. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification. Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886 [TBL] [Abstract][Full Text] [Related]
10. Integrating surface plasmon resonance biosensor-based interaction kinetic analyses into the lead discovery and optimization process. Danielson UH Future Med Chem; 2009 Nov; 1(8):1399-414. PubMed ID: 21426056 [TBL] [Abstract][Full Text] [Related]
11. Biosensor-surface plasmon resonance: A strategy to help establish a new generation RNA-specific small molecules. Vo T; Paul A; Kumar A; Boykin DW; Wilson WD Methods; 2019 Sep; 167():15-27. PubMed ID: 31077819 [TBL] [Abstract][Full Text] [Related]
12. Emerging role of surface plasmon resonance in fragment-based drug discovery. Navratilova I; Hopkins AL Future Med Chem; 2011 Oct; 3(14):1809-20. PubMed ID: 22004086 [TBL] [Abstract][Full Text] [Related]
13. Fragment screening by SPR and advanced application to GPCRs. Shepherd CA; Hopkins AL; Navratilova I Prog Biophys Mol Biol; 2014; 116(2-3):113-23. PubMed ID: 25301577 [TBL] [Abstract][Full Text] [Related]
14. Fragment based drug design: from experimental to computational approaches. Kumar A; Voet A; Zhang KY Curr Med Chem; 2012; 19(30):5128-47. PubMed ID: 22934764 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of fragment screening methods on the p38α kinase: new methods, new insights. Pollack SJ; Beyer KS; Lock C; Müller I; Sheppard D; Lipkin M; Hardick D; Blurton P; Leonard PM; Hubbard PA; Todd D; Richardson CM; Ahrens T; Baader M; Hafenbradl DO; Hilyard K; Bürli RW J Comput Aided Mol Des; 2011 Jul; 25(7):677-87. PubMed ID: 21732248 [TBL] [Abstract][Full Text] [Related]
16. Label free fragment screening using surface plasmon resonance as a tool for fragment finding - analyzing parkin, a difficult CNS target. Regnström K; Yan J; Nguyen L; Callaway K; Yang Y; Diep L; Xing W; Adhikari A; Beroza P; Hom RK; Riley B; Rudolph D; Jobling MF; Baker J; Johnston J; Konradi A; Bova MP; Artis DR PLoS One; 2013; 8(7):e66879. PubMed ID: 23861750 [TBL] [Abstract][Full Text] [Related]
17. Surface plasmon resonance biosensor based fragment screening using acetylcholine binding protein identifies ligand efficiency hot spots (LE hot spots) by deconstruction of nicotinic acetylcholine receptor α7 ligands. de Kloe GE; Retra K; Geitmann M; Källblad P; Nahar T; van Elk R; Smit AB; van Muijlwijk-Koezen JE; Leurs R; Irth H; Danielson UH; de Esch IJ J Med Chem; 2010 Oct; 53(19):7192-201. PubMed ID: 20828128 [TBL] [Abstract][Full Text] [Related]
18. Identification of B. anthracis N(5)-carboxyaminoimidazole ribonucleotide mutase (PurE) active site binding compounds via fragment library screening. Lei H; Jones C; Zhu T; Patel K; Wolf NM; Fung LW; Lee H; Johnson ME Bioorg Med Chem; 2016 Feb; 24(4):596-605. PubMed ID: 26740153 [TBL] [Abstract][Full Text] [Related]
19. SPR Biosensors in Direct Molecular Fishing: Implications for Protein Interactomics. Florinskaya A; Ershov P; Mezentsev Y; Kaluzhskiy L; Yablokov E; Medvedev A; Ivanov A Sensors (Basel); 2018 May; 18(5):. PubMed ID: 29783662 [TBL] [Abstract][Full Text] [Related]
20. Developments in SPR Fragment Screening. Chavanieu A; Pugnière M Expert Opin Drug Discov; 2016; 11(5):489-99. PubMed ID: 26948323 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]